# Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery

> **NCT04180943** · PHASE4 · COMPLETED · sponsor: **Bassett Healthcare** · enrollment: 85 (actual)

## Conditions studied

- Anesthesia, Local

## Interventions

- **DRUG:** interscalene nerve block

## Key facts

- **NCT ID:** NCT04180943
- **Lead sponsor:** Bassett Healthcare
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-13
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04180943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04180943, "Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04180943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*